|
RBC Implementation - Columbia |
Red Blood Cell Indices |
Columbia University |
Case Only |
|
|
|
|
|
VUMC_T1DM |
Type 1 Diabetes |
VUMC |
Case, Control |
|
|
|
|
|
Geisinger Implementation |
Ovarian/Uterine Cancer (OvUtCa) |
Geisinger |
Case, Control |
200 |
8,257 |
|
|
|
CCHMC Primary Validation |
Migraine |
|
Case Only |
|
|
92% |
|
|
Statin and MACE Implementation - Columbia |
Statins and MACE |
Columbia University |
Case, Control |
41 |
570 |
|
|
|
Mayo Clinic eMERGE III Implementation |
Clostridium Difficile Colitis |
Mayo Clinic |
Case, Control |
103 |
4,494 |
|
|
|
CHOP Pneumonia |
Pneumonia- VUMC eMERGE v5.1 |
CHOP |
Case, Control |
|
|
|
|
|
RA_Columbia |
Rheumatoid Arthritis (RA) |
Columbia University |
Case, Control |
8 |
2,793 |
|
|
|
Marshfield SLE Implementation |
SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria |
Marshfield Clinic Research Institute |
Case Only |
|
|
|
|
|
Implementation of NAFLD by VUMC |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
VUMC |
Case, Control |
677 |
15,878 |
|
|
|
GERD Implementation - Columbia |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Columbia University |
Case, Control |
76 |
259 |
|
|
|
Group Health and UW Zoster Implementation |
Herpes Zoster |
Group Health and UW |
Case, Control |
25 |
25 |
100%, 96% |
100% |
|
Cardiac Conduction Vanderbilt Implementation |
Cardiac Conduction (QRS) |
Vanderbilt University |
Case Only |
103 |
|
97% |
|
|
Geisinger Impl |
Depression |
Geisinger |
Case, Control |
|
|
|
|
|
Marshfield Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Marshfield Clinic Research Foundation |
Case, Control |
59 |
1,564 |
|
|
|
Validation on 75 RA patients |
Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort |
Vanderbilt University |
Case Only |
|
|
97% |
|
|
Marshfield DILI algorithm implementation |
Drug Induced Liver Injury |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
10% |
|
|
MGB - T2DM |
Type 2 Diabetes - PRS Evaluation |
|
Case Only |
|
|
|
|
|
Northwestern University Implementation |
Hearing Loss |
Northwestern University |
Case, Control |
|
|
|
|
|
NU GWAS CRC cases and controls |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
|
|
|
|
|
Warfarin-Columbia |
Warfarin dose/response |
Columbia University |
Case Only |
|
|
|
|
|
Columbia_T1DM |
Type 1 Diabetes |
|
Case, Control |
|
|
|
|
|
Columbia Implementation |
Ovarian/Uterine Cancer (OvUtCa) |
Columbia University |
Case, Control |
19 |
1,265 |
|
|
|
Geisinger Impl |
Migraine |
Geisinger |
Case, Control |
762 |
5,266 |
|
|
|
ADHD Validation (CCHMC) |
ADHD phenotype algorithm |
Cincinnati Children's Hospital Medical Center |
Case, Control |
|
|
89%, 95% |
|
